Compare · IINN vs MDLN
IINN vs MDLN
Side-by-side comparison of Inspira Technologies Oxy B.H.N. Ltd. (IINN) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IINN and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $52.27B, about 3132.2x IINN ($16.7M).
- Over the past year, IINN is down 73.3% and MDLN is down 2.3% - MDLN leads by 71.0 points.
- IINN has been more active in the news (17 items in the past 4 weeks vs 4 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 2 for IINN).
- Company
- Inspira Technologies Oxy B.H.N. Ltd.
- Medline Inc.
- Price
- $0.38+0.51%
- $39.80-3.23%
- Market cap
- $16.7M
- $52.27B
- 1M return
- -34.36%
- +7.36%
- 1Y return
- -73.32%
- -2.33%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2025
- News (4w)
- 17
- 4
- Recent ratings
- 2
- 25
Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Latest IINN
- SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
- QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director
- SEC Form 25-NSE filed by Inspira Technologies Oxy B.H.N. Ltd.
- COO Shabtay Abraham was granted 550,000 units of Ordinary Shares, increasing direct ownership by 41% to 1,882,713 units (SEC Form 4)
- Chief Business Officer Rozanovich Yoav was granted 550,000 units of Ordinary Shares (SEC Form 4)
- Chief Technology Officer Yechezkely Hayon Daniella was granted 550,000 units of Ordinary Shares, increasing direct ownership by 71% to 1,330,000 units (SEC Form 4)
- Chief Financial Officer Tehila Yafit was granted 550,000 units of Ordinary Shares, increasing direct ownership by 63% to 1,420,000 units (SEC Form 4)
- SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
- QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company
- SEC Form EFFECT filed by Inspira Technologies Oxy B.H.N. Ltd.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)